(Q40975452)

25 September 2017

1 reference

title

Pyoderma gangrenosum: classification and management (English)

1 reference

25 September 2017

1 reference

Powell FC

1

1 reference

25 September 2017

Su WP

series ordinal

2

1 reference

25 September 2017

Perry HO

series ordinal

3

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 March 1996

1 reference

Journal of the American Academy of Dermatology

25 September 2017

published in

1 reference

25 September 2017

volume

34

1 reference

25 September 2017

issue

3

1 reference

25 September 2017

page(s)

395-409; quiz 410-2

1 reference

Cutaneous manifestations of neutrophilic disease. A study of seven cases.

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum in infancy: the youngest reported patient

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma Gangrenosum and Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum in pediatric acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum: a reappraisal of associated systemic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum in immunosuppressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum involving the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum of penile and scrotal skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum of the scalp

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

1 reference

7 January 2021

Ulcerative Colitis and the Skin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Successful treatment of eruptive pyoderma gangrenosum with intravenous vancomycin and mezlocillin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pustular pyoderma gangrenosum associated with ulcerative colitis in childhood. Report of two cases and review of the literature.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum, subcorneal pustular dermatosis and IgA paraproteinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum followed by subcorneal pustular dermatosis in a patient with IgA paraproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Bowel-associated dermatosis-arthritis syndrome: bowel bypass syndrome without bowel bypass

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

The bowel-associated dermatosis--arthritis syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Disseminated pustular dermatosis in polycythemia vera. Relationship with neutrophilic dermatosis of myeloproliferative disorders: study of neutrophil function

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

AN ACUTE FEBRILE NEUTROPHTLIC DERMATOSTS.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Acute febrile neutrophilic dermatosis (Sweet's syndrome) and myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Sweet syndrome in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Sweet's syndrome: pathogenesis and associated conditions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Acute febrile neutrophilic dermatosis (Sweet's syndrome) and the related conditions of "bowel bypass" syndrome and bullous pyoderma gangrenosum.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Neutrophilic dermatosis of myeloproliferative disorders. Atypical forms of pyoderma gangrenosum and Sweet's syndrome associated with myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Neutrophilic vascular reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Erythema elevatum diutinum: A clinical and histopathologic study of 13 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Erythema elevatum diutinum: a clinicopathological study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Erythema elevatum diutinum in a patient with acquired immunodeficiency syndrome. Another clinical simulator of Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

The association of hairy cell leukemia with unusual immunologic disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Erythema elevatum diutinum--an unusual association with ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Erythema elevatum diutinum in a patient with Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Superficial granulomatous pyoderma: A localized vegetative form of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Superficial granulomatous pyoderma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma vegetans in association with chronic ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma vegetans: association with diffuse T cell lymphoma (large cell type)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Development of folliculitis and pyoderma gangrenosum in association with abdominal pain in a patient following treatment with isotretinoin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum associated with antiphospholipid antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum presenting as Fournier's gangrene

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Cutaneous cryptococcosis simulating pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Sporotrichosis masquerading as pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum; a clinical study of nineteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

1 reference

7 January 2021

Skin lesions in ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum, altered delayed hypersensitivity and polyarthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Hypogammaglobulinemia in Pyoderma Gangrenosum*

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum associated with selective hereditary IgA deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Hyperimmunoglobulin E and impaired neutrophil functions in a case of pyoderma gangrenosum: effect of clofazimine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum with altered cellular immunity and dermonecrotic factor

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Immunologic and Biochemical Studies on a Patient with Pyoderma Gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Leukocyte chemotaxis and pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pharmacological modulation of neutrophil phagocytic function in a patient with recurrent sepsis, pyoderma gangrenosum and impaired phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Skin manifestations in congenital deficiency of leucocyte-adherence glycoproteins (CDLG)

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum in acute myeloid leukaemia during immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum in an allogeneic bone marrow transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

T Helper-suppressor Cell Imbalance in Pyoderma Gangrenosum, with Relapsing Polychondritis and Corneal Keratolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Minimizing the risk of post-operative pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum and monoclonal gammopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangraenosum (dermatitis ulcerosa) and monoclonal (IgA) globulin healed after melphalan treatment. Case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Suppression of leukocyte chemotaxis by human IgA myeloma components

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

1 reference

7 January 2021

Sweet's syndrome associated with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum in myelodysplasia and acute leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum complicating non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum with cutaneous T-cell lymphoma manifested as lower extremity ulcers--case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Active chronic hepatitis and pyoderma gangrenosum: report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

The association of chronic active hepatitis with pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum and sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum: the histology of the primary lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

PYODERMA GANGRENOSUM AS THE PRESENTING SIGN OF REGIONAL ILEITIS: OBSERVATIONS REGARDING THE PATHOGENESIS OF THE SKIN LESIONS

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Letter: Pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Histopathologic and immunopathologic study of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

The evolution of pyoderma gangrenosum. A clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Direct immunofluorescence in pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum with an unusual syndrome of ulcers, vesicles, and arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

The treatment of pyoderma gangrenosum with sodium cromoglycate

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Cromolyn sodium in 2% aqueous solution under an occlusive hydrocolloid dressing may be effective adjunctive treatment in management of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum treated with hyperbaric oxygen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum associated with systemic lupus erythematosus: response to pulse steroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Clofazimine treatment of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Treatment of pyoderma gangrenosum with clofazimine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Idiopathic pyoderma gangrenosum and impaired lymphocyte function: failure of azathioprine and corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Chlorambucil--an effective corticosteroid-sparing therapy for pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Pyoderma gangrenosum treated with cyclosporin A

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Cyclosporine treatment of pyoderma gangrenosum

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Treatment of pyoderma gangrenosum with cyclosporine: results in seven patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Treatment of pyoderma gangrenosum with cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Bullous pyoderma gangrenosum and multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

Does intestinal resection heal the pyoderma gangrenosum of inflammatory bowel disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990428-4

7 January 2021

10.1016/S0190-9622(96)90428-4

Identifiers

DOI

1 reference

25 September 2017

1 reference